BioWorld

July 19, 2002

View Archived Issues

Orphan Medical Cataplexy Drug Xyrem Approved By FDA

Nearly two years after the company filed its new drug application, Orphan Medical Inc. said after the markets closed Wednesday it won FDA approval for Xyrem, designed to treat cataplexy associated with narcolepsy. (BioWorld Today) Read More

Senate Passes Reimportation Amendment; Vote Weeks Away

Read More

Brain's Fissured, Furrowed Gray Matter Replicated In Transgenic Mice To See Cortex Overgrowth

Read More

Focused On Drug Discovery, Scion Closes $17.5M Round

Read More

Other News To Note

Read More